Welcome to the IPE Reference Hub. This site uses cookies. Read our policy.

Franklin Templeton

2022 Top 500 ranking: 15

New Wave Innovation Spurring Biotech Rejuvenation

new wave innovation spurring biotech rejuvenation

Akin to science fiction narratives, a patient’s own immune cells could now be clinically harvested and sent to laboratories to be genetically engineered to recognise specific antigens, before they are enlarged and infused back into the body as highly effective cancer-killing agents.

This is premium content

You are not logged in, Sign in or register to request access. 
Please note: If you had prior access to this content you may need to sign in again.

Asset Owners

If you are an institutional investor you are eligable for free access to all premium content.


Asset Managers

Asset managers with enhanced profiles are eligable for full access.

Please sign-in using your work email address or:



Premium subscription 

Investment services

Non-asset management investment service providers are able to purchase a subscription for access to premium content such as:

  • Latest industry thought leadership, news and research from the managers
  • Research and asset class or investment theme

Get access to premium content subscribe today